Using an appointment-based medication synchronization program can improve adherence rates among patients taking chronic medications, according to a new study published in the Journal of Managed Care & Specialty Pharmacy.
Using an appointment-based medication synchronization (ABMS) program can improve adherence rates among patients taking chronic medications, according to a new study published in the Journal of Managed Care & Specialty Pharmacy.
Researchers from Virginia Commonwealth University School of Pharmacy compared patients receiving ABMS with patients receiving usual care. Patients were included in the study if they were taking medications in 1 of 6 categories: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers; beta blockers; dihydropyridine calcium channel blockers; thiazide diuretics; metformin; and statins.
“An ABMS program in a community pharmacy setting was associated with higher rates of adherence and persistence for patients who had been taking chronic medications for at least 6 months,” the authors wrote.
Patients in the ABMS program experienced 3 actions: synchronization of medications so refills come due on a single day of the month; a monthly call from the pharmacy to the patient or family caregiver; and a scheduled appointment to pick up medications at the pharmacy and speak with the pharmacist if necessary.
The patients enrolled had been taking their chronic medications for at least 6 months. This patient population was chosen because nonadherence is more likely to occur in patients filling new prescriptions, and approximately half of patients discontinue therapy in the first 6 months.
The researchers found that participants in the ABMS program experienced adherence rates of 55% to 84%, depending on medication class, while participants with usual care only experience adherence rates of 37% to 62%. Overall, the odds of adherence were 2.3 to 3.6 times greater with ABMS. Usual care participants also became nonpersistent more often.
“This study shows that ABMS programs can improve medication adherence and persistence for patients who are newly prescribed or currently taking chronic medications,” the authors concluded.
In addition to clinical benefits, the findings about the ABMS program can have financial implications for health plans as improving adherence can help Medicare Advantage plans improve their star ratings, which in turn makes them eligible for bonuses and rebates, the researchers explained.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More